SELLAS Life Sciences Group Income Statement (2011-2024) | SLS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Revenue & cost
Revenue 1.44M1.90M5.70M1.90M1.00M
Cost of Revenue 0.10M0.10M0.10M
Gross Profit 5.60M1.80M0.90M
Operating items
Research & Development 2.16M50.65M2.66M25.79M5.08M1.86M2.28M2.37M2.77M4.28M3.46M4.54M3.39M4.61M5.53M4.28M5.85M7.17M5.92M5.81M5.10M
Share-based Compensation (IS) 17.17M
Selling, General & Administrative 3.12M40.32M1.75M46.29M1.53M2.20M1.99M2.12M3.29M3.56M2.80M2.44M2.53M3.02M3.09M2.86M3.60M4.11M3.13M3.55M3.08M
Other Operating Expenses -0.08M-0.16M0.02M-0.16M-0.16M-0.11M5.70M-0.01M0.21M0.12M0.18M
Operating Expenses 5.28M90.96M4.41M72.08M6.61M4.06M4.27M4.49M6.06M7.95M6.35M6.98M11.62M17.73M8.62M7.15M9.45M11.28M9.05M9.36M8.18M
Operating Income -5.28M-4.06M-4.27M-4.49M-4.16M-2.25M-4.45M-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
EBIT -5.28M-77.27M-23.54M-72.58M-12.05M-4.06M-4.27M-4.49M-4.16M-2.25M-4.45M-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
Non-operating items
Interest & Investment Income 0.66M-0.02M0.59M0.01M
Other Non Operating Income 13.94M-19.11M-1.09M-5.45M
Non Operating Income 13.94M-19.13M-1.09M-5.45M-0.01M0.12M0.33M0.18M0.09M0.04M
Net income details
EBT -5.28M-77.27M-23.54M-72.58M-12.05M-4.06M-4.27M-4.49M-4.16M-2.25M-4.45M-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
Tax Provisions -1.05M-2.76M
Profit After Tax 3.84M-77.27M-24.76M-112.24M-9.29M-4.14M-4.42M-4.47M-3.72M-2.40M-4.61M-7.08M-6.60M-16.74M-8.41M-7.02M-9.12M-11.10M-8.84M-9.27M-8.14M
Income from Continuing Operations -5.28M-77.27M-23.54M-71.53M-9.29M-4.06M-4.27M-4.49M-4.16M-2.25M-4.45M-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
Consolidated Net Income -5.28M-77.27M-1.22M-40.71M-40.71M-4.06M-4.27M-4.49M-4.16M-2.25M-4.45M-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
Income towards Parent Company -5.28M-77.27M-1.22M-40.71M-40.71M-4.06M-4.27M-4.49M-4.16M-2.25M-4.45M-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
Preferred Dividend Payments 0.08M
Net Income towards Common Stockholders -5.28M-77.27M-1.22M-40.71M-40.71M-4.22M-4.42M-4.47M-3.72M-2.40M-4.61M-7.08M-6.60M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
Additional items
EPS (Basic) -0.01M-0.05M-0.49-0.02M-0.11-0.66-0.66-0.53-0.28-0.16-0.30-0.45-0.42-1.05-0.41-0.34-0.43-0.47-0.31-0.33-0.25
EPS (Weighted Average and Diluted) -0.26-0.66-0.53-0.28-0.16-0.30-0.45-0.42-1.05-0.41-0.34-0.43-0.47-0.31-0.33-0.25
Shares Outstanding (Weighted Average) 612.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.46M0.50M4.53M4.87M6.72M9.46M9.46M15.08M15.08M15.87M15.89M15.91M15.91M20.55M20.55M20.59M28.35M28.35M32.06M32.06M56.27M64.33M64.33M
Shares Outstanding (Diluted Average) 20.32M6.72M8.42M7.98M14.88M15.27M15.87M15.48M15.90M20.29M20.56M19.40M23.55M28.35M28.36M27.78M44.81M57.63M68.25M
EBITDA -5.28M-77.27M-23.54M-72.58M-12.05M-4.06M-4.27M-4.49M-4.16M-2.25M-4.45M-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-9.05M-9.36M-8.18M
Tax Rate 1.45%22.91%